Related references
Note: Only part of the references are listed.Intravenous immunoglobulin replacement therapy in common variable immunodeficiency induces B cell depletion through differentiation into apoptosis-prone CD21low B cells
Milica Mitrevski et al.
IMMUNOLOGIC RESEARCH (2014)
Intravenous immunoglobulin induces a functional silencing program similar to anergy in human B cells
Jean-Francois Seite et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Dysregulated extracellular signal-regulated kinase signaling associated with impaired B-cell receptor endocytosis in patients with common variable immunodeficiency
Marcella Visentini et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)
Natural Autoantibodies to Fcγ Receptors in Intravenous Immunoglobulins
Hicham Bouhlal et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
IVIG regulates BAFF expression in patients with chronic inflammatory demyelinating polyneuropathy (CIDP)
Christian Ritter et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
The Advantage of Specific Intravenous Immunoglobulin (sIVIG) on Regular IVIG: Experience of the Last Decade
Nina Svetlicky et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2013)
Intravenous immunoglobulin inhibits BAFF production in chronic inflammatory demyelinating polyneuropathy - A new mechanism of action?
Sandra Bick et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Expression of B Cell Activating Factor (BAFF) and BAFF-binding Receptors in Rheumatoid Arthritis
Maria J. Leandro et al.
JOURNAL OF RHEUMATOLOGY (2013)
Intravenous immunoglobulin therapy: how does IgG modulate the immune system?
Inessa Schwab et al.
NATURE REVIEWS IMMUNOLOGY (2013)
B cells and CD22 are dispensable for the immediate antiinflammatory activity of intravenous immunoglobulins in vivo
Inessa Schwab et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
BAFF and innate immunity: new therapeutic targets for systemic lupus erythematosus
Fabien B. Vincent et al.
IMMUNOLOGY AND CELL BIOLOGY (2012)
Mechanisms of Disease Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Erwin W. Gelfand
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Regulation of B cell functions by the sialic acid-bincing receptors Siglec-G and CD22
Julia Jellusova et al.
FRONTIERS IN IMMUNOLOGY (2012)
B cells are resistant to immunomodulation by 'IVIg-educated' dendritic cells
Mohan S. Maddur et al.
AUTOIMMUNITY REVIEWS (2011)
Telomere-dependent replicative senescence of B and T cells from patients with type 1a common variable immunodeficiency
Marcella Visentini et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2011)
The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders
Mark Ballow
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2011)
Intravenous immunoglobulin induces proliferation and immunoglobulin synthesis from B cells of patients with common variable immunodeficiency: A mechanism underlying the beneficial effect of IVIg in primary immunodeficiencies
Jagadeesh Bayry et al.
JOURNAL OF AUTOIMMUNITY (2011)
TLR9 responses of B cells are repressed by intravenous immunoglobulin through the recruitment of phosphatase
Jean-Francois Seite et al.
JOURNAL OF AUTOIMMUNITY (2011)
IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
Aharon Kessel et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2011)
Enrichment of Sialylated IgG by Lectin Fractionation Does Not Enhance the Efficacy of Immunoglobulin G in a Murine Model of Immune Thrombocytopenia
Theresa Guhr et al.
PLOS ONE (2011)
Fcγ receptor IIB (FcγRIIB) maintains humoral tolerance in the human immune system in vivo
Anne Baerenwaldt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
IVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes
Jean-Francois Seite et al.
BLOOD (2010)
Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones
Isabelle Isnardi et al.
BLOOD (2010)
Inhibition of B cell-mediated antigen presentation by intravenous immunoglobulins (IVIg)
Dominic Paquin Proulx et al.
CLINICAL IMMUNOLOGY (2010)
Regression of Systemic Lupus Erythematosus After Development of an Acquired Toll-like Receptor Signaling Defect and Antibody Deficiency
Marcella Visentini et al.
ARTHRITIS AND RHEUMATISM (2009)
Intravenous immunoglobulin preparations have no direct effect on B cell proliferation and immunoglobulin production
S. Heidt et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2009)
Intravenous immunoglobulin up-regulates the expression of the inhibitory FcγIIB receptor on B cells
Kalina A. Nikolova et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Spontaneous internalization of IVIg in activated B cells
Dominic Paquin Proulx et al.
IMMUNOLOGY LETTERS (2009)
Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy
Bjoern Tackenberg et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells
Mirzokhid Rakhmanov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Anti-inflammatory actions of intravenous immunoglobulin
Falk Nimmerjahn et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
Immunomodulation of human B cells following treatment with intravenous immunoglobulins involves increased phosphorylation of extracellular signal-regulated kinases 1 and 2
Nathalie Dussault et al.
INTERNATIONAL IMMUNOLOGY (2008)
A disease-specific fraction isolated from IVIG is essential for the immunosuppressive effect of IVIG in experimental autoimmune myasthenia gravis
Sara Fuchs et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Serum BAFF expression in patients with myasthenia gravis
Jee Young Kim et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
B-cell anergy: from transgenic models to naturally occurring anergic B cells?
John C. Cambier et al.
NATURE REVIEWS IMMUNOLOGY (2007)
BAFF, a new target for intravenous immunoglobulin in autoimmunity and cancer
Laetitia Le Pottier et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2007)
Fc gamma RIIb controls bone marrow plasma cell persistence and apoptosis
Zou Xiang et al.
NATURE IMMUNOLOGY (2007)
Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus
Sean R. Christensen et al.
IMMUNITY (2006)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Fc gamma receptors: Old friends and new family members
F Nimmerjahn et al.
IMMUNITY (2006)
the role of CD22 and other inhibitory co-receptors in B-cell activation
L Nitschke
CURRENT OPINION IN IMMUNOLOGY (2005)
Resistance to CpG DNA-induced autoimmunity through tolerogenic B cell antigen receptor ERK signaling
LX Rui et al.
NATURE IMMUNOLOGY (2003)
Intravenous immunoglobulins induce the in vitro differentiation of human B lymphocytes and the secretion of IgG
MJ de Grandmont et al.
BLOOD (2003)
Pooled human gammaglobulin modulates surface molecule expression and induces apoptosis in human B cells
M Toyoda et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Advances in immunology: Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin.
MD Kazatchkine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
The B cell superantigen-like interaction of intravenous immunoglobin (IVIG) with Fab fragments of VH 3-23 and 3-30/3-30.5 germline gene origin cloned from a patient with Kawasaki disease is enhanced after IVIG therapy
S Leucht et al.
CLINICAL IMMUNOLOGY (2001)
Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor
A Samuelsson et al.
SCIENCE (2001)
Share Paper
